Auxilium On a Roll ...
Health Care: Drugs
ADVENTRX Pharmaceuticals Inc. (ANX: AMEX)
$0.51 -0.01 | -2.11%
06/04/12 - 03:14 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 0.52 |
| 52 Week High | 4.21 |
| 52 Week Low | 0.52 |
| Avg. Daily Vol. (Mil) | 0.45 |
| Beta (3 year) | 2.88 |
| Share Related Items | |
| Mkt Cap (Mil) | 24.86 |
| Shares Out (Mil) | 47.72 |
| Float (Mil) | 47.13 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 23.00 |
| Current Ratio | 24.30 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 0.00 |
| Price/Book | 0.47 |
| Price/Cash Flow | -1.70 |
| Per Share Data | |
| Earnings | -0.43 |
| Sales | 0.00 |
| Book Value | 1.11 |
| Cash Flow | -0.30 |
| Business Summary | |
|---|---|
| ADVENTRX Pharmaceuticals, Inc. is a development-stage biopharmaceutical company, whose fundamental business is focused on in-licensing, developing and commercializing proprietary product candidates for the treatment of cancer. | |
| General Information | |
| 12390 El Camino Real
Suite 150 San Diego, CA 92130 |
|
| www.adventrx.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 13 | |
| CEO: Brian M. Culley,M.S. | |
| Short Interest | |
| Current Month (Mil) | 2.93 |
| Previous Month (Mil) | 2.89 |
| Short Interest Ratio (Days) | 9.70 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -25.10 |
| Return on Investments | -27.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with ANX
- Portfolio NameUser Type
- Uservlady 1
- Usertesting
- Contributor5 Stocks Under-$10 Setting ...
- ContributorBreakout Stocks Of The Week...
- ContributorHot Biotech Trades for Seco...
- UserDusty's Tracker
- UserDustel's Growth Stocks
- UserOwn
- UserASCO 2010 Part 2
- UserCDBrevard Portfolio 1
Latest ANX Headlines from TheStreet
- For Biotech, 'Fail' is Making a Big Comeback 03.12.12 | 08:03 am
- ADVENTRX Stock Gaps Down On Today's Open (ANX) 11.11.11 | 08:11 am
- 5 Stocks Under $10 Setting Up to Trade Higher 09.15.11 | 01:09 pm
- 5 Stocks Setting Up to Break Out 09.09.11 | 03:09 pm
- ADVENTRX Stock Hits New 52-Week Low (ANX) 08.10.11 | 09:08 am
- Adventrx: FDA Rejects Lung Cancer Drug 08.10.11 | 07:08 am
- ADVENTRX Stock Gaps Down On Today's Open (ANX) 08.08.11 | 10:08 am
- Biotech Stock Mailbag: Sangamo Biosciences 07.22.11 | 05:07 am
- Biotech Stock Live Chat 07.15.11 | 12:07 pm
- Biotech Stock Mailbag: Adventrx Pharma 07.15.11 | 05:07 am
Press Releases for ANX
- ADVENTRX Pharmaceuticals To Sponsor & Present At The Martin Center's 2012 Sickle Cell Disease Conference - PR Newswire 04.16.12 | 08:04 am
- ADVENTRX Announces Establishment Of Regulatory Advisory Board - PR Newswire 04.09.12 | 08:04 am
- Vista Partners Updates Coverage On ADVENTRX Pharmaceuticals, Inc.; $3.50 Target Price - PR Newswire 03.21.12 | 09:03 am
- ADVENTRX CEO Selected By Combined Health Agencies As A 2012 Health Hero - PR Newswire 03.15.12 | 08:03 am
- ADVENTRX Pharmaceuticals To Present At The 14th Annual BIO CEO & Investor Conference On February 14 - PR Newswire 02.07.12 | 08:02 am
- Vista Partners Publishes February 2012 Newsletter - PR Newswire 02.02.12 | 09:02 am
- Vista Partners Updates Coverage On ADVENTRX Pharmaceuticals, Inc.; $3.50 Target Price - PR Newswire 12.15.11 | 09:12 am
- ADVENTRX Meets With FDA To Discuss Development Plans For ANX-188 - PR Newswire 12.01.11 | 08:12 am
- ADVENTRX Announces Closing Of Public Offering - PR Newswire 11.16.11 | 03:11 pm
- ADVENTRX Prices Public Offering Of Stock - PR Newswire 11.11.11 | 08:11 am
Partner Headlines for ANX
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 12.19.11 | 09:12 am
- Why CytRx Corporation Is Still A Big Biotech 'If' Play - Seeking Alpha 12.14.11 | 09:12 am
- Blue Horseshoe - Or Someone - Likes Anaconda Mining; Shares Pop 20% After Selling Iron Ore Assets - NASDAQ 12.07.11 | 06:12 pm
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 12.02.11 | 09:12 am
- 5 Healthcare Stocks To Consider - Seeking Alpha 09.01.11 | 08:09 am
- Company News for August 11, 2011 - Corporate Summary - Zacks 08.11.11 | 10:08 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.10.11 | 09:08 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 07.21.11 | 09:07 am
- Adventrx Pharmaceuticals: Undervalued Based on Product Approval Potential - Seeking Alpha 07.21.11 | 08:07 am
- Upcoming PDUFA Dates for Sub-$5 Stocks - Seeking Alpha 07.05.11 | 09:07 am
